Tag: ReNu

World News 10 M 1440052130

Organogenesis Studies Optimistic Interim Evaluation of Second Section 3 Scientific Trial of ReNu for Knee Osteoarthritis By Investing.com

CANTON, Mass., Nov. 11, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: NASDAQ:), a number one regenerative drugs firm targeted…

Business